Cat. No.: DIA-0230227
Product Information | |
---|---|
CAS No. | 17318-31-9 |
Synonyms | 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine |
Formula | C9H11N5O |
Molecular Weight | 205.22 |
SMILES | NC1=C2N=C[N](C3CCCO3)C2=NC=N1 |
Product Description | SQ22536 is an inhibitor of adenylyl cyclase with an IC50 of 1.4 μM. It can inhibit PGE1-stimulated increases in cAMP levels in intact human platelets. |
Format & Storage | |
---|---|
Purity | > 97% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.